Market Cap 17.70M
Revenue (ttm) 94.14M
Net Income (ttm) -12.41M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -13.18%
Debt to Equity Ratio 0.58
Volume 355,800
Avg Vol 365,508
Day's Range N/A - N/A
Shares Out 44.21M
Stochastic %K 18%
Beta 1.47
Analysts Sell
Price Target $4.50

Latest News on HBIO

Harvard Bioscience Announces CFO Transition

Apr 10, 2025, 4:45 PM EDT - 17 days ago

Harvard Bioscience Announces CFO Transition


Harvard Bioscience, Inc. (HBIO) Q4 2024 Earnings Call Transcript

Mar 12, 2025, 11:19 AM EDT - 6 weeks ago

Harvard Bioscience, Inc. (HBIO) Q4 2024 Earnings Call Transcript


Harvard Bioscience, Inc. (HBIO) Q2 2024 Earnings Call Transcript

Aug 11, 2024, 7:09 AM EDT - 9 months ago

Harvard Bioscience, Inc. (HBIO) Q2 2024 Earnings Call Transcript


Harvard Bioscience: Rally In Shares Losing Steam

Jun 20, 2023, 5:06 PM EDT - 2 years ago

Harvard Bioscience: Rally In Shares Losing Steam